From seeds of Arctium lappa L. (Asteraceae) we obtained arctigenin (1), arctiin (2), chlorogenic acid (3), 4,5-dicaffeoylquinic acid (4), 3,5-dicaffeoylquinic acid (5), 3,4-dicaffeoylquinic acid (6), matairesinol (11), isolappaol A (12), lappaol F (14), and lappaol B (15), together with 1:1 mixtures of isolappaol C (7) and lappaol C (8), arctignan E (9) and arctignan D (10), and 12 and lappaol A (13), while 3,3',4'-tri-O-demethylarctigenin (16), 3,3'-di-O-demethyl-4'dehydroxyarctigenin (17), and 3-O-demethylarctigenin (18) were obtained by anaerobic microbiological metabolism of 1. Then, we evaluated the in vitro preferential cytotoxic activity of these pure compounds and 1:1 mixtures, together with enterodiol (19) and enterolactone (20), against human pancreatic cancer PANC-1 cells in nutrient-deprived medium (NDM). Among them, 1 and 18 showed potent activity, with PC 50 values of 1.75 and 4.38 M, respectively, while 11, 15, and 17 showed mild activity with PC 50 values of 31.1, 30.9, and 38.7 M, respectively. By comparing their structures and PC 50 values, the following structural moieties could be concluded to be important for the preferential cytotoxicity of 1: 1) the 3-hydroxy-4-methoxyphenyl group at the 2-position on the -butyrolactone ring, 2) the less polar substituent at the 3-position on the -butyrolactone ring, and 3) the -butyrolactone ring.
Pancreatic cancer is the most aggressive cancer of all and has an exceptionally high global mortality rate, with an estimated 267,000 deaths worldwide in 2008 and ranks 8th or 9th as the most frequent cause of cancer death worldwide [1] . Moreover, it has been estimated that the number of deaths from pancreatic cancer will reach 484,000 by 2030 [1] . Pancreatic cancer rapidly metastases and leads to the death of patients in a short period after diagnosis. Thus, the 5-year survival rate of patients with pancreatic cancer is the lowest among several cancers [2, 3] . Though surgery is the only treatment that offers any prospect of potential cure, chemotherapy with 5-fluorouracil and gemcitabine is also used for palliative therapy of advanced pancreatic cancer. However, pancreatic cancer is largely resistant to most known chemotherapeutic agents, including 5-fluorouracil and gemcitabine [4] . Therefore, effective chemotherapeutic agents that target pancreatic cancer are urgently needed.
Tumor cells, in general, proliferate very fast, and the demand for essential nutrients and oxygen is always high. The immediate environment of cancers increasing in size, however, often becomes heterogeneous and some regions of large cancers often possess microenvironmental niches, which exhibit a significant gradient of critical metabolites, including oxygen, glucose, other nutrients, and growth factors [5] . Thus, many cancer cells obtain their critical metabolites by randomly recruiting new blood vessels, a phenomenon commonly known as angiogenesis, to survive under such severe conditions. However, human pancreatic cancer survives with an extremely poor blood supply and becomes more malignant [6] . The method by which pancreatic cancer survives is by obtaining a remarkable tolerance to extreme nutrient starvation [7] . Therefore, it has been hypothesized that eliminating the tolerance of cancer cells to nutrition starvation may allow a novel biochemical approach known as "anti-austerity" for cancer therapy [8, 9] .
In this regard, we screened 500 medicinal plants used in Kampo medicine to identify agents that preferentially reduce the survival of nutrient-deprived human pancreatic cancer PANC-1 cells. The screen led to the isolation of arctigenin (1) as the active principle of Arctium lappa [10] . In A. lappa, arctigenin (1) is mainly contained as its glucoside, arctiin (2), and after consumption, 2 is deglucosidated to 1, followed by demethylation and dehydroxylation by intestinal bacteria [11] [12] [13] . Thus, we developed the preparation method of arctigenin-rich extract from seeds of A. lappa [14] . In the course of the development, we obtained chlorogenic acid (3) [15] , 4,5-dicaffeoylquinic acid (4) [15] , 3,5-dicaffeoylquinic acid (5) [15] , 3,4-dicaffeoylquinic acid (6) [15] , matairesinol (11) [16, 17] , isolappaol A (12) [16, 18] , lappaol F (14) [16, 19] , and lappaol B (15) [16, 20] , together with 1 and 2. In addition, we also obtained three 1:1 mixtures consisting of isolappaol C (7) [21] and lappaol C (8) [16, 22] , arctignan E (9) [16] and arctignan D (10) [16] , and 12 and lappaol A (13) [16, 20] . Their structures ( Figure 1 ) were identified based on the HPLC retention times and NMR spectroscopic data. We also prepared three known metabolites, 3,3',4'-tri-Odemethylarctigenin (16) [23], 3,3'-di-O-demethyl-4'dehydroxyarctigenin (17) [23] , and 3-O-demethylarctigenin (18) [24] , by anaerobic microbiological metabolism of 1.
Previously, it was reported that arctigenin (1) showed potent preferential cytotoxicity against human pancreatic PANC-1 cell line in nutrient-deprived medium (NDM), but its glucoside, arctiin (2), showed no cytotoxicity [9] . However, we had not examined the preferential cytotoxicity of other constituents. Thus, we evaluated the in vitro preferential cytotoxic activity of twelve pure compounds (1, 3-6, 11, 12, 14-18) and three 1:1 mixtures (7+8, 9+10, 12+13), together with enterodiol (19) and enterolactone (20) [13] , against human pancreatic cancer PANC-1 cells in nutrient-deprived medium (NDM). In this paper, we report the results. The cell number at the start of the starvation was considered to be 100%. The numbers 1, 3-6, 11, 12 , and 14-20 mean the data of (-)-arctigenin (1) and (-)-arctigenin-relating compounds 3-6, 11, 12, and 14-20, respectively. The numbers 7+8, 9+10, and 12+13 mean the data of the 1:1 mixtures of (-)-arctigenin-relating compounds 7 and 8, 9 and 10, and 12 and 13, respectively.
The PANC-1 cell line is highly resistant to nutrient starvation, and can survive in NDM, even after 48 h of starvation [6] [7] [8] . However, this tolerance to nutrient starvation was remarkably eliminated by arctigenin (1) in a concentration-dependent manner, as reported previously [10] . Of the other compounds tested, 5, 6, 11, 12, 12+13, 14-18, and 20 showed preferential cytotoxicity with different potencies, while others showed no cytotoxicity either under normal or nutrient-deprived conditions (Figure 2 ). Their preferential cytotoxicities, which were expressed as the 50% cytotoxic concentration in NDM (PC 50 value), showed arctigenin (1) itself to be the most potent (PC 50 , 1.75 M), but 3-O-demethylarctigenin (18) also showed potent activity (PC 50 , 4.38 M) ( Table 1) 
Experimental
Materials: (-)-Arctigenin-relating compounds 3-15 were isolated from a 30% EtOH extract of seeds of Arctium lappa L., whereas anaerobic metabolites 16-18 were obtained by metabolizing arctiin (2) with the anaerobic bacteria, Ruminococcus productus JCM1471 and Eggerthella lenta JCM10764 (Japan Collection of Microorganisms, RIKEN Bioresource Center, Saitama, Japan). The purity of the tested samples was checked by HPLC analyses to be >95%. Enterodiol (19, >95%) and enterolactone (20, >95%) were purchased from Sigma-Aldrich Inc. (St. Louis, MO, USA).
(-)-Arctigenin-relating compounds 3-15:
Seeds of Arctium lappa L., collected at Zhejiang Province in People's Republic of China, were purchased from Shibata Ltd. (Tokyo, Japan; Lot No. 7JS23K82). From the seeds of A. lappa, 30% EtOH extract was prepared by the patent procedure [14] . In brief, powdered seeds (300 g) were treated with water (1.5 L, 1 h) at 22°C with stirring and then refluxed for 1 h. After filtration, the residual material was washed with water (0.5 L) and then extracted with 30% EtOH (0.95 L, reflux, 1 h). After filtration, the residual material was washed with 30% EtOH (0.5 L) and the extract concentrated under reduced pressure and then freeze-dried to give a 30% EtOH extract (23.0 g, 7.7% yield). The 30% EtOH extract was fractionated into AcOEtsoluble and AcOEt-insoluble fractions, and the AcOEt-soluble fraction was separated by silica gel CC with AcOEt-n-hexane (5:5, 6:4, 7:3, 9:1), AcOEt, and then MeOH-AcOEt (1:9, 2:8, 3:7) (each 2 L). Each fraction was monitored by HPLC and subjected to MPLC separation on a Lobar RP-18 column (0.2% phosphoric acid-CH 3 CN, 10:1 to 10:5) to give 1, 2, 11, 12, 14, and 15 , together with the mixtures of 7 and 8 (1:1) and of 9 and 10 (1:1). The mixture of 12 and 13 (1:1) was obtained by heating the acidic eluate of 7 and 8 (1:1). Separation of the AcOEt-insoluble fraction gave compounds 3-6.
Anaerobic bacterial metabolites 16-18: Arctiin (2) was incubated with a mixture of the anaerobic bacteria Ruminococcus productus JCM1471 and Eggerthella lenta JCM10764 in 100 mL of GAM broth (Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) for 15 days. The culture broth collected was partitioned between AcOEt and water, and the AcOEt-soluble fraction was concentrated and separated with MPLC by using a Lober RP-8 column (0.05 mol/L NaH 2 PO 4 aq.-CH 3 CN (10:1 to 10:10)). Each fraction was checked by HPLC and the fractions containing 16, 17, and 18 were respectively combined and filtered through a short silica gel column to give crystalline 16-18. Preferential cytotoxicity: Preferential cytotoxicity was determined as previously described [10] . In brief, PANC-1 cells (2 × 10 4 cells/well) were seeded in 96-well plates (Corning Inc., Corning, NY, USA) and incubated in fresh DMEM at 37°C in 5% CO 2 and 95% air for 24 h. The cells were washed with Dulbecco's phosphate-buffered saline (PBS, Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) before the medium was replaced with either DMEM or NDM containing serial dilutions of the test samples. After 24 h of incubation, the cells were washed with PBS, and 100 L of DMEM containing 10% WST-8 cell counting kit solution (Dojindo, Kumamoto, Japan) was added to the wells. After 3 h of incubation, the absorbance was measured at 450 nm. Cell viability was calculated from the mean values for 3 wells using the following equation: Cell viability (%) = [(Abs (test samples) − Abs (blank) )/(Abs (control) − Abs (blank) )] × 100. The preferential cytotoxicity was expressed as the concentration at which 50% of cells died preferentially in NDM (PC 50 ).
Cells and culture:

